← Back to Search

IVE Therapy vs Traditional Rehabilitation for Concussion (INVENT Trial)

N/A
Recruiting
Led By Michael C Schubert, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Service members with mTBI and civilian patients with vestibular hypofunction, both of which reports vestibular symptoms (i.e. dizziness, imbalance).
Be older than 18 years old
Must not have
Greater than or equal to 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly, up to 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is comparing a new device that improves the vestibulo-ocular reflex against traditional vestibular rehabilitation in people with mild traumatic brain injury or vestibular hypofunction.

Who is the study for?
This trial is for active duty service members with mild traumatic brain injury (mTBI) and civilians who have vestibular hypofunction, experiencing symptoms like dizziness or imbalance. Participants must be at least 18 years old.
What is being tested?
The study compares traditional Vestibular Rehabilitation Therapy (VPT) to a new device called Incremental Velocity Error (IVE), which aims to enhance the performance of the vestibulo-ocular reflex that helps with balance and eye movements.
What are the potential side effects?
Since this trial involves physical therapy techniques and a non-invasive device, side effects may include temporary increased dizziness or nausea during exercises, fatigue, headache, or discomfort from using the IVE equipment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a mild traumatic brain injury or vestibular hypofunction and experience dizziness or imbalance.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly, up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly, up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in vestibulo-ocular reflex (VOR) Gain
Secondary study objectives
5 min Rate of Perceived Exertion for the Patrol Exertion Multitask Test (PEMT)
Baseline oculomotor function assessed with Videonystagmography/Electronystagmography (VNG/ENG)
Baseline vestibular function assessed with Rotary Chair
+25 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: IVE/VPT 3 week CrossoverExperimental Treatment2 Interventions
Subjects will randomly be placed in one of two groups (IVE or VPT) involving daily exercise for 3 weeks, 3 weeks washout, and then crossover into the other group for a final 3 weeks. The Incremental Velocity Error (IVE) group uses a device worn on the head that delivers a moving target during head motion; while Traditional Vestibular Rehabilitation (VPT) uses the traditional eye and head turning rehabilitation exercises. Gait and balance training will not start until the washout period.
Group II: IVE/VPT 6 week CrossoverActive Control2 Interventions
Subjects will randomly be placed in one of two groups (IVE or VPT) involving daily exercise for 5 weeks, 6 weeks washout, and then crossover into the other group for a final 5 weeks. The Incremental Velocity Error (IVE) group uses a device worn on the head that delivers a moving target during head motion; while Traditional Vestibular Rehabilitation (VPT) uses the traditional eye and head turning rehabilitation exercises. Gait and balance training offered throughout each of the 5 weeks epochs of training.
Group III: IVE/VPT 3 week crossoverActive Control2 Interventions
Subjects will randomly be placed in one of two groups (IVE or VPT) involving every other day exercise for 3 weeks, 3 weeks washout, and then crossover into the other group for a final 3 weeks. The Incremental Velocity Error (IVE) group uses a device worn on the head that delivers a moving target during head motion; while Traditional Vestibular Rehabilitation (VPT) uses the traditional eye and head turning rehabilitation exercises. Gait and balance training offered throughout the 3 weeks of exercise.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,323 Previous Clinical Trials
14,874,163 Total Patients Enrolled
Fort Belvoir Community HospitalFED
13 Previous Clinical Trials
2,000 Total Patients Enrolled
Neuroscience Research AustraliaOTHER
12 Previous Clinical Trials
1,709 Total Patients Enrolled

Media Library

Incremental Velocity Error (IVE) Clinical Trial Eligibility Overview. Trial Name: NCT03846830 — N/A
Vestibular Neuropathy Research Study Groups: IVE/VPT 6 week Crossover, IVE/VPT 3 week crossover, IVE/VPT 3 week Crossover
Vestibular Neuropathy Clinical Trial 2023: Incremental Velocity Error (IVE) Highlights & Side Effects. Trial Name: NCT03846830 — N/A
Incremental Velocity Error (IVE) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03846830 — N/A
~17 spots leftby May 2025